Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Covington
McKinsey
Baxter
Chubb
Deloitte

Generated: September 23, 2019

DrugPatentWatch Database Preview

Patent: 7,569,554

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,569,554
Title:Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
Abstract: The invention relates to the therapeutic use of immunostimulatory oligonucleotides and/or immunomers in combination with chemotherapeutic agents to provide a synergistic therapeutic effect.
Inventor(s): Kandimalla; Ekambar R. (Southboro, MA), Agrawal; Sudhir (Shrewsbury, MA), Wang; Daqing (Bedford, MA), Bhagat; Lakshmi (Framingham, MA), Yu; Dong (Westboro, MA)
Assignee: Idera Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:10/846,167
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,569,554
Patent Claims:see list of patent claims

Details for Patent 7,569,554

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX Orphan search
Spectrum Pharms ZEVALIN ibritumomab tiuxetan INJECTABLE; INJECTION 125019 001 2002-02-19 ➤ Sign Up Idera Pharmaceuticals, Inc. (Cambridge, MA) 2023-05-16 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Chinese Patent Office
UBS
Daiichi Sankyo
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.